Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback